Cargando…
The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer
In theranostics (i.e., therapy and diagnostics) radiopharmaceuticals are used for both therapeutic and diagnostic purposes by targeting one specific tumor receptor. Biologically relevant compounds, e.g., receptor ligands or drugs, are labeled with radionuclides to form radiopharmaceuticals. The poss...
Autores principales: | Poot, Alex J., Lam, Marnix G. E. H., van Noesel, Max M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710543/ https://www.ncbi.nlm.nih.gov/pubmed/33330054 http://dx.doi.org/10.3389/fonc.2020.578286 |
Ejemplares similares
-
Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments
por: Samim, Atia, et al.
Publicado: (2021) -
PSMA Theranostics: Current Status and Future Directions
por: Rahbar, Kambiz, et al.
Publicado: (2018) -
Roles of lncRNAs in childhood cancer: Current landscape and future perspectives
por: Liu, Fei, et al.
Publicado: (2023) -
Current status of theranostics in prostate cancer
por: Virgolini, Irene, et al.
Publicado: (2017) -
PSMA-Targeting Imaging and Theranostic Agents—Current Status and Future Perspective
por: Debnath, Sashi, et al.
Publicado: (2022)